Novel penA mutations identified in Neisseria gonorrhoeae with decreased susceptibility to ceftriaxone isolated between 2000 and 2014 in Japan

Journal of Antimicrobial Chemotherapy

Volumn 71, Issue 9, 2016, Pages 2466-2470

  Seike, Kensaku ^a   Yasuda, Mitsuru ^a   Hatazaki, Kyoko ^a   Mizutani, Kosuke ^a   Yuhara, Kazuya ^b   Ito, Yasuhisa ^c   Fujimoto, Yoshinori ^d   Ito, Shin ^e   Tsuchiya, Tomohiro ^a   Yokoi, Shigeaki ^a   Nakano, Masahiro ^a   Deguchi, Takashi ^a  

^a GIFU UNIVERSITY   (Japan)

^b Takayama Red Cross Hospital   (Japan)

^c Ibi Kosei Hospital Ibi   (Japan)

^d OGAKI MUNICIPAL HOSPITAL   (Japan)

^e IClinic   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; CEFTRIAXONE;

ADULT; ANTIBIOTIC RESISTANCE; DNA MUTATIONAL ANALYSIS; DRUG EFFECTS; FEMALE; GENETICS; GONORRHEA; HUMAN; ISOLATION AND PURIFICATION; JAPAN; MALE; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MUTATION; NEISSERIA GONORRHOEAE; YOUNG ADULT;

ADULT; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CEFTRIAXONE; DNA MUTATIONAL ANALYSIS; DRUG RESISTANCE, BACTERIAL; FEMALE; GONORRHEA; HUMANS; JAPAN; MALE; MICROBIAL SENSITIVITY TESTS; MUTATION; NEISSERIA GONORRHOEAE; YOUNG ADULT;

EID: 85013271556     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkw161     Document Type: Article

References (20)

1. Ito M, Yasuda M, Yokoi S et al. Remarkable increase in central Japan in 2001-2002 of Neisseria gonorrhoeae isolates with decreased susceptibility to penicillin, tetracycline, oral cephalosporins, and fluoroquinolones. Antimicrob Agents Chemother 2004; 48: 3185-7.
2. Hamasuna R, Yasuda M, Ishikawa K et al. The second nationwide surveillance of the antimicrobial susceptibility of Neisseria gonorrhoeae from male urethritis in Japan, 2012-2013. J Infect Chemother 2005; 21: 340-5.
3. Ito M, Deguchi T, Mizutani KS et al. Emergence and spread of Neisseria gonorrhoeae clinical isolates harboring mosaic-like structure of penicillinbinding protein 2 in Central Japan. Antimicrob Agents Chemother 2005; 49: 137-43.
4. Ohnishi M, Golparian D, Shimuta K et al. Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob Agents Chemother 2011; 55: 3538-45.
5. Unemo M, Golparian D, Nicholas R et al. High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure. Antimicrob Agents Chemother 2012; 56: 1273-80.
6. Cámara J, Serra J, Ayats J et al. Molecular characterization of two highlevel ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain. J Antimicrob Chemother 2012; 67: 1858-60.
7. Tanaka M, Nakayama H, Huruya K et al. Analysis of mutations within multiple genes associated with resistance in a clinical isolate of Neisseria gonorrhoeae with reduced ceftriaxone susceptibility that shows a multidrug-resistant phenotype. Int J Antimicrob Agents 2006; 27: 20-6.
8. Chen SC, Yin YP, Dai XQ et al. Antimicrobial resistance, genetic resistance determinants for ceftriaxone and molecular epidemiology of Neisseria gonorrhoeae isolates in Nanjing, China. J Antimicrob Chemother 2014; 69: 2959-65.
9. Unemo M, Golparian D, Stary A et al. First Neisseria gonorrhoeae strain with resistance to cefixime causing gonorrhoea treatment failure in Austria, 2011. Euro Surveill 2011; 16: pii=19998.
10. Lahra MM, Ryder N, Whiley DM. A new multidrug-resistant strain of Neisseria gonorrhoeae in Australia. N Engl J Med 2014; 371: 1850-1.
11. Deguchi T, Yasuda M, Hatazaki K et al. New clinical strain of Neisseria gonorrhoeae with decreased susceptibility to ceftriaxone, Japan. Emerg Infect Dis 2016; 22: 142-4.
12. Warner DM, Shafer WM, Jerse AE. Clinically relevant mutations that cause derepression of the Neisseria gonorrhoeae MtrC-MtrD-MtrE efflux pump system confer different levels of antimicrobial resistance and in vivo fitness. Mol Microbiol 2008; 70: 462-78.
13. Lindberg R, Fredlund H, Nicholas R et al. Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime and ceftriaxone: association with genetic polymorphisms in penA, mtrR, porB1b, and ponA. Antimicrob Agents Chemother 2007; 51: 2117-22.
14. Whiley DM, Jacobsson S, Tapsall JWet al. Alterations of the pilQ gene in Neisseria gonorrhoeae are unlikely contributors to decreased susceptibility to ceftriaxone and cefixime in clinical gonococcal strains. J Antimicrob Chemother 2010; 65: 2543-7.
15. Pandori M, Barry PM, Wu A et al. Mosaic penicillin-binding protein 2 in Neisseria gonorrhoeae isolates collected in 2008 in San Francisco, California. Antimicrob Agents Chemother 2009; 53: 4032-4.
16. Unemo M, Nicholas RA. Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea. Future Microbiol 2012; 7: 1401-22.
17. Shimuta K, Unemo M, Nakayama S et al. Antimicrobial resistance and molecular typing of Neisseria gonorrhoeae isolates in Kyoto and Osaka, Japan, 2010 to 2012: intensified surveillance after identification of the first strain (H041) with high-level ceftriaxone resistance. Antimicrob Agents Chemother 2013; 57: 5225-32.
18. Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically-Eighth Edition: Approved Standard M07-A8. CLSI, Wayne, PA, USA, 2009.
19. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twentieth Informational Supplement M100-S20. CLSI, Wayne, PA, USA, 2010.
20. Yasuda M, Ito S, Kido A et al. A single 2 g oral dose of extended-release azithromycin for treatment of gonococcal urethritis. J Antimicrob Chemother 2014; 69: 3116-8.